Adcock Ingram Holdings (JSE:AIP) ROE % Adjusted to Book Value : 9.85% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings ROE % Adjusted to Book Value?

Adcock Ingram Holdings's ROE % for the quarter that ended in Dec. 2023 was 16.35%. Adcock Ingram Holdings's PB Ratio for the quarter that ended in Dec. 2023 was 1.66. Adcock Ingram Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 9.85%.

Adcock Ingram Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Adcock Ingram Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings ROE % Adjusted to Book Value Chart

Adcock Ingram Holdings Annual Data

Trend

Sep13

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

7.04

8.66

9.32

10.54

10.56

Adcock Ingram Holdings Semi-Annual Data
	Mar14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															9.92	10.42	11.80	9.89	9.85

Competitive Comparison of Adcock Ingram Holdings's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adcock Ingram Holdings's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's ROE % Adjusted to Book Value falls into.

Adcock Ingram Holdings ROE % Adjusted to Book Value Calculation

Adcock Ingram Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	16.90%	/	1.60
	=	10.56%

Adcock Ingram Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	16.35%	/	1.66
	=	9.85%

Adcock Ingram Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Adcock Ingram Holdings (JSE:AIP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682

Website

https://www.adcock.com

Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.